Descargar PDF

Otros usuarios también vieron estos artículos

Safety and efficacy of sodium-glucose co-transporter-2 inhibitors and aldosterone inhibitors combinations in chronic kidney disease: A systematic review and meta-analysis Ahmed W. Hageen, Reem Sayad, Alyaa Khaled Abdelmonem, Katia Latifa, Lina Musallam, Moustafa Abouelkheir, Sherif Mira, Ahmed Awad, Ahmed Afsa, Waleed Nassar, Gehad El Ashal, Mohamed Elmasry, Eshak I. Bahbah
10.1016/j.nefro.2025.501345
Evidence for the use of a nonsteroidal mineralocorticoid receptor antagonist for the treatment of chronic kidney disease Mariana Morais David Pliças, Bernardo Marques da Silva, Edgar Avito Fernandes de Almeida
10.1016/j.nefro.2024.10.004
Beneficial long-term effect of aldosterone antagonist added to a traditional blockade of the renin–angiotensin–aldosterone system among patients with obesity and proteinuria Enrique Morales, Eduardo Gutiérrez, Jara Caro, Angel Sevillano, Jorge Rojas-Rivera, Manuel Praga
10.1016/j.nefro.2015.09.008